Differential modulation of cell cycle, apoptosis and PPARγ2 gene expression by PPARγ agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 5, 2006, Pages 283-293

  Hampel, Jade K A ^a,b   Brownrigg, Leon M ^a   Vignarajah, Dayalan ^a   Croft, Kevin D ^a   Dharmarajan, Arun M ^c   Bentel, Jacqueline M ^c   Puddey, Ian B ^a   Yeap, Bu B ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; 2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 9 HYDROXYOCTADECADIENOIC ACID; CIGLITAZONE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL LEVEL; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; DRUG SPECIFICITY; FATTY ACID ANALYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MODULATION; MONOCYTE; PRIORITY JOURNAL;

ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; GENE EXPRESSION; HUMANS; HYPOGLYCEMIC AGENTS; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; MONOCYTES; PPAR GAMMA; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; U937 CELLS;

EID: 33646459486     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.03.002     Document Type: Article

References (40)

1. Diamant M., and Heine R.J. Thiazolidinediones in Type 2 diabetes mellitus. Drugs 63 (2003) 1373-1405
2. Rosen E.D., and Spiegelman B.M. PPARγ: a nuclear regulator of metabolism, differentiation and cell growth. J. Biol. Chem. 276 (2001) 37731-37734
3. Francis G.A., Fayard E., Picard F., and Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65 (2003) 261-311
4. Hammarstedt A., Andersson C.X., Rotter Sopasakis V., and Smith U. The effects of PPARγ ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005) 65-75
5. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
6. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83 (1995) 803-812
7. Grommes C., Landreth G.E., and Heneka M.T. Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists. Lancet Oncol. 5 (2004) 419-429
8. Theocharis S., Margeli A., Vielh P., and Kourakils G. Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators. Cancer Treat. Rev. 30 (2004) 545-554
9. 2. Cell Growth Differ. 11 (2000) 49-61
10. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., and Evans R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidised LDL. Cell 93 (1998) 241-252
11. Nagy L., Tontonoz P., Alvarez J.G.A., Chen H., and Evans R.M. Oxidised LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93 (1998) 229-240
12. Kaduce T.L., Figard P.H., Leifur R., and Spector A.A. Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells. J. Biol. Chem. 264 (1989) 6823-6830
13. Waddington E.I., Croft K.D., Sienuarine K., Latham B., and Puddey I.B. Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 167 (2003) 111-120
14. Leesnitzer L.M., Parks D.J., and Bledsoe R.K. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41 (2001) 6640-6650
15. Waddington E., Sienuarine K., Puddey I., and Croft K. Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal. Biochem. 292 (2001) 234-244
16. Dharmarajan A.M., Hisheh S., Singh B., Parkinson S., Tilly K.I., and Tilly J. Anti-oxidants mimic the ability of chorionic gonadotrophin to suppress apoptosis in the rabbit corpus luteum in vitro: A novel role for superoxide dismutase in regulating bax expression. Endocrinology 140 (1999) 2555-2561
17. Yeap B.B., Krueger R.G., and Leedman P.J. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 140 (1999) 3282-3291
18. Stumvoll M. Thiazolidinediones-some recent developments. Expert Opin. Investig. Drugs 12 (2003) 1179-1187
19. Hsueh W.A., and Law R.E. PPARγ and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1891-1895
20. Roberts A.W., Thomas A., Rees A., and Evans M. Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis: current evidence and future directions. Curr. Opin. Lipidol. 14 (2002) 567-573
21. Barbier O., Pineda Torra I., Duguay Y., et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 717-726
22. Kitamura S., Miyazaki Y., Shinomura Y., Kondo S., Kanayama S., and Matsuzawa Y. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn. J. Cancer Res. 90 (1999) 75-80
23. Eibl G., Wente M.N., Reber H.A., and Hines O.J. Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis. Biochem. Biophys. Res. Commun. 287 (2001) 522-529
24. Rumi M.A., Sato H., Ishihara S., et al. Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma. Br. J. Cancer 84 (2001) 1640-1647
25. Takashima T., Fujiwara Y., Higuchi K., et al. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int. J. Oncol. 19 (2001) 465-471
26. Chinetti G., Griglio S., Antonucci M., et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273 (1998) 25573-25580
27. 2 and the precursors in monocytic leukaemia U937. Pharmacology 71 (2004) 181-191
28. Marx N., Sukhova G., Murphy C., Libby P., and Plutzky J. Macrophages in human atheroma contain PPARγ. Am. J. Pathol. 153 (1998) 17-23
29. Geng Y.-J., and Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1370-1380
30. Littlewood T.D., and Bennett M.R. Apoptotic cell death in atherosclerosis. Curr. Opin. Lipidol. 14 (2003) 469-475
31. Wang M., and Tafuri S. Modulation of PPARγ activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis. J. Cell Biochem. 89 (2003) 38-47
32. 2-induced apoptosis does not require PPARγ in breast cancer cells. J. Lipid Res. 43 (2002) 1818-1828
33. 2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism. Biochem. Biophys. Res. Commun. 302 (2003) 415-420
34. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., and Evans R.M. PPAR-γ-dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation. Nature Med. 7 (2001) 48-52
35. Fajas L., Auboeuf D., Raspe E., et al. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272 (1997) 18779-18789
36. Fajas L., Fruchart J.C., and Auwerx J. PPARgamma3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Lett. 30 (1998) 55-60
37. Rieusset J., Andreelli F., Auboeuf D., et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-γ in human adipocytes. Diabetes 48 (1999) 699-705
38. Werman A., Hollenberg A., Solanes G., Bjorbaek C., Vidal-Puig A.J., and Flier J.S. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARγ). Differential activity of PPARγ1 and -2 isoforms and influence of insulin,. J. Biol. Chem. 272 (1997) 20230-20235
39. Ren D., Collingwood T.N., Rebar E.J., Wolffe A.P., and Camp H.S. PPARgamma knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis. Genes Dev. 16 (2002) 27-32
40. Shureiqi I., Jiang W., Zuo X., et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 9968-9973